[{"address1": "Fitzwilliam Court", "address2": "1st Floor Leeson Close", "city": "Dublin", "zip": "D02 YW24", "country": "Ireland", "phone": "353 1 669 4820", "website": "https://www.iterumtx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Mr. Corey N. Fishman", "age": 58, "title": "President, CEO & Director", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": 1372710, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Judith M. Matthews", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 778817, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael W. Dunne M.D.", "age": 63, "title": "Strategic Advisor & Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 168148, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sailaja  Puttagunta M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 755894, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tom  Loughman Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Louise  Barrett", "title": "Senior Vice President of Legal Affairs & Secretary", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven I. Aronin M.D.", "title": "Senior VP & Head of Clinical Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.49, "open": 1.56, "dayLow": 1.49, "dayHigh": 1.605, "regularMarketPreviousClose": 1.49, "regularMarketOpen": 1.56, "regularMarketDayLow": 1.49, "regularMarketDayHigh": 1.605, "beta": 2.348, "forwardPE": -0.50333333, "volume": 402839, "regularMarketVolume": 402839, "averageVolume": 617011, "averageVolume10days": 255830, "averageDailyVolume10Day": 255830, "bidSize": 1400, "askSize": 900, "marketCap": 20287454, "fiftyTwoWeekLow": 0.622, "fiftyTwoWeekHigh": 2.5, "fiftyDayAverage": 1.6623, "twoHundredDayAverage": 1.222855, "currency": "USD", "enterpriseValue": 4027510, "floatShares": 11990607, "sharesOutstanding": 13435400, "sharesShort": 1165923, "sharesShortPriorMonth": 47850, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.0868, "heldPercentInsiders": 0.01853, "heldPercentInstitutions": 0.09204, "shortRatio": 0.87, "shortPercentOfFloat": 0.0887, "impliedSharesOutstanding": 13435400, "bookValue": 0.263, "priceToBook": 5.7414446, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -31099000, "trailingEps": -2.43, "forwardEps": -3.0, "lastSplitFactor": "1:15", "lastSplitDate": 1660780800, "enterpriseToEbitda": -0.095, "52WeekChange": 0.5520834, "SandP52WeekChange": 0.3219322, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ITRM", "underlyingSymbol": "ITRM", "shortName": "Iterum Therapeutics plc", "longName": "Iterum Therapeutics plc", "firstTradeDateEpochUtc": 1527255000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "2a47ad90-f2ae-3045-b6c4-2f53ded8d73b", "messageBoardId": "finmb_318354064", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.51, "targetHighPrice": 7.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.5, "targetMedianPrice": 6.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 35892000, "totalCashPerShare": 2.75, "ebitda": -42214000, "totalDebt": 20214000, "quickRatio": 2.199, "currentRatio": 2.35, "debtToEquity": 588.986, "returnOnAssets": -0.49382, "returnOnEquity": -1.7286301, "freeCashflow": 2447875, "operatingCashflow": -30752000, "financialCurrency": "USD", "trailingPegRatio": null}]